ArticleBMJ open2025

Adjunctive dobutamine in patients with septic cardiomyopathy and tissue hypoperfusion: a blinded randomised controlled multicentre trial study protocol of the ADAPT-dobutamine trial.

Philippe Vignon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.